# GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study

> clinical trial · VERIFIED · 2026-07-30

Status: RECRUITING · Sponsor: W.L.Gore & Associates · Condition: Stroke

- Company: W.L.Gore & Associates
- Sector: Stroke
- Primary source: https://clinicaltrials.gov/study/NCT03821129

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.